跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kaempherol
首页
药物
Kaempherol
Experimental
Small Molecule
Kaempherol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
15
H
10
O
6
CAS 编号
520-18-3
UNII ID
731P2LE49E
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Composition of Indole-3-carbinol and either catechin, kaempherol, myricetin or luteolin for potentiating antitumour effect and for treating tumours
申请人: GRINDEKS JSC
优先权: 2010
EP
Composition of tegafur, Indole-3-carbinol and either catechin, kaempherol, myricetin or luteolin for potentiating antitumour effect and for treating tumours
申请人: GRINDEKS JSC
优先权: 2010
EP
Composition of caffeic acid phenethyl ester (CAPE) and one of catechin, kaempherol and myricetin for potentiating antitumour effect and for treating tumours
申请人: GRINDEKS JSC
优先权: 2010
EP
Composition of TEGAFUR, caffeic acid phenethyl ester (CAPE) and either catechin, kaempherol, myricetin or luteolin for potentiating antitumour effect and for treating tumours
申请人: GRINDEKS JSC
优先权: 2010
EP
药物
反馈